The European drugs watchdog is recommending doctors do not prescribe the anti-obesity drug rimonabant, also known as Acomplia. The European Medicines Agency has said the risk of serious psychiatric problems and even suicide are too high.
Read article on the BBC News website (UK)
Friday, October 31, 2008
The European drugs watchdog is recommending doctors do not prescribe the anti-obesity drug rimonabant, also known as Acomplia.
Posted by Willow at 12:02 pm
Labels: Acomplia, adverse side-effects, anti-obesity drug, rimonabant, suicide
Subscribe to: